Site Announcement
For the latest results and update on CytoDyn’s Phase 2 CRC trial and more, here’s a link to our April 30, 2026 investor update webinar
| Date | Form | Description | XBRL | Pages | |
|---|---|---|---|---|---|
| 05/11/20 | EFFECT | Notice of Effectiveness |
|
1 | |
| 05/06/20 | CORRESP | A correspondence can be sent as a document with another submission type or can be sent as a separate submission. |
|
1 | |
| 05/05/20 | 4 | Statement of changes in beneficial ownership of securities |
|
3 | |
| 05/04/20 | 4 | Statement of changes in beneficial ownership of securities |
|
3 | |
| 04/30/20 | S-3/A | Registration statement for specified transactions by certain issuers |
|
34 | |
| 04/28/20 | 8-K | Current report filing |
|
3 | |
| 04/27/20 | 8-K | Current report filing |
|
3 | |
| 04/23/20 | 8-K | Current report filing |
|
7 | |
| 04/22/20 | 3/A | Initial statement of beneficial ownership of securities |
|
3 | |
| 04/22/20 | 4 | Statement of changes in beneficial ownership of securities |
|
1 |
